Avitar, Inc. (AVTI)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
May 8, 2025, 4:00 PM EDT

Avitar Company Description

Avitar, Inc. is a holding company which through its subsidiaries designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States.

It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine such as crack; marijuana; and methamphetamines, including meth and ecstasy.

The company also provides foam disposable products including medical-grade hydrophilic polyurethane foam disposables such as wound dressings comprising Hydrasorb, a wound dressing product for exudating wounds; and various custom foam products comprising a sinus dressing and a device used by astronauts for relieving ear pressure while in a pressurized space suit.

In addition, it develops specialty wound dressings for the cardiac catheter lab market, as well as the Illizarov Dressing used for dressing external bone fixators in orthopedic procedures.

The company markets its products and services to employers, diagnostic test distributors, medical supply companies, governmental agencies, schools, and corporations through direct sales force and strategic partners, as well as through a network of distributors.

Avitar, Inc. was founded in 1986 and is based in Canton, Massachusetts with Additional office in Calgary, Canada.

Avitar, Inc.
Avitar logo
Country United States
Founded 1986
Industry Medical Devices
Sector Healthcare
Employees 36
CEO Cory Gelmon

Contact Details

Address:
65 Dan Road
Canton, Delaware 02021
United States
Phone 781-821-2440

Stock Details

Ticker Symbol AVTI
Exchange OTCMKTS
Stock Type Common Stock
Fiscal Year October - September
Reporting Currency USD
ISIN Number US0538013048
SIC Code 2835

Key Executives

Name Position
Cory H. Gelmon Chief Executive Officer, President, Treasurer and Secretary